Literature DB >> 27464318

Group A Streptococcal Infections Are Associated With Increased Risk of Pediatric Neuropsychiatric Disorders: A Taiwanese Population-Based Cohort Study.

Han-Cheng Wang1,2,3, Chi-Ieong Lau1, Che-Chen Lin4,5,6, Anna Chang1, Chia-Hung Kao7.   

Abstract

OBJECTIVE: This study evaluated the association between group A streptococcal (GAS) infections and the risks of developing tic disorders, obsessive-compulsive disorder (OCD), and attention-deficit/hyperactivity disorder (ADHD).
METHODS: We conducted a follow-up cohort study in 2014 using Taiwan's National Health Insurance Research Database. The study cohort consisted of patients younger than 18 years with newly diagnosed GAS infection (ICD-9-CM codes 034 [streptococcal sore throat and scarlet fever] and 482.31 [pneumonia due to Streptococcus, group A]) from 2001 to 2010. All patients having GAS infection codes between 1996 and 2000 were excluded. We assessed the patients' risks of developing tic disorders, OCD, and ADHD (ICD-9-CM codes 300.3 [obsessive-compulsive disorders], 301.4 [obsessive-compulsive personality disorder], 307.2 [tic disorder, unspecified], and 314 [attention deficit disorder]) and compared these risks with those of a control cohort. The primary outcomes of this study were the overall neuropsychiatric disorder occurrence and the occurrence of separate subtypes.
RESULTS: We examined 2,596 patients and 25,960 controls. The incidence of neuropsychiatric disorders in the GAS infection cohort (60.42 per 10,000 person-years) was significantly higher than that in the comparison cohort (49.32 per 10,000 person-years) (hazard ratio [HR] = 1.22; 95% CI, 1.00-1.49). The largest increased risk was for tic disorders (HR = 1.63; 95% CI, 1.02-2.62). Patients hospitalized for GAS infection had a 1.96-fold higher risk of neuropsychiatric disorders than did people without GAS infection (HR = 1.96; 95% CI, 1.23-3.12), and there was no difference in risk between outpatients with GAS infection and people without GAS infection (HR = 1.14; 95% CI, 0.92-1.41). Patients with moderate or high frequencies of GAS infection-related clinic visits had much higher risks of developing a neuropsychiatric disorder and, specifically, tic disorders and ADHD (all P values for trend < .05). These risks were not increased in patients with a low frequency of clinic visits.
CONCLUSIONS: Our results confirmed an association between previous group A streptococcal infection and neuropsychiatric disorders. © Copyright 2016 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27464318     DOI: 10.4088/JCP.14m09728

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  13 in total

1.  Association of Streptococcal Throat Infection With Mental Disorders: Testing Key Aspects of the PANDAS Hypothesis in a Nationwide Study.

Authors:  Sonja Orlovska; Claus Høstrup Vestergaard; Bodil Hammer Bech; Merete Nordentoft; Mogens Vestergaard; Michael Eriksen Benros
Journal:  JAMA Psychiatry       Date:  2017-07-01       Impact factor: 21.596

2.  PANDAS/PANS in childhood: Controversies and evidence.

Authors:  Colin Wilbur; Ari Bitnun; Sefi Kronenberg; Ronald M Laxer; Deborah M Levy; William J Logan; Michelle Shouldice; E Ann Yeh
Journal:  Paediatr Child Health       Date:  2018-12-09       Impact factor: 2.253

Review 3.  Childhood Physical Health and Attention Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Modifiable Factors.

Authors:  Marvin So; Eric J Dziuban; Caitlin S Pedati; Joseph R Holbrook; Angelika H Claussen; Brenna O'Masta; Brion Maher; Audrey A Cerles; Zayan Mahmooth; Laurel MacMillan; Jennifer W Kaminski; Margaret Rush
Journal:  Prev Sci       Date:  2022-08-10

4.  The genetic architecture of pneumonia susceptibility implicates mucin biology and a relationship with psychiatric illness.

Authors:  William R Reay; Michael P Geaghan; Murray J Cairns
Journal:  Nat Commun       Date:  2022-06-29       Impact factor: 17.694

5.  Breastfeeding in Pediatric Acute-Onset Neuropsychiatric Syndrome: An Italian Observational Study.

Authors:  Manuel Murciano; Davide Maria Biancone; Francesca De Luca; Denise Piras Marafon; Cristiana Alessia Guido; Alberto Spalice
Journal:  Front Pediatr       Date:  2021-07-08       Impact factor: 3.418

Review 6.  Searching for host immune-microbiome mechanisms in obsessive-compulsive disorder: A narrative literature review and future directions.

Authors:  Emily A Troyer; Jordan N Kohn; Gertrude Ecklu-Mensah; Gajender Aleti; David R Rosenberg; Suzi Hong
Journal:  Neurosci Biobehav Rev       Date:  2021-02-24       Impact factor: 9.052

Review 7.  Individualized Immunological Data for Precise Classification of OCD Patients.

Authors:  Hugues Lamothe; Jean-Marc Baleyte; Pauline Smith; Antoine Pelissolo; Luc Mallet
Journal:  Brain Sci       Date:  2018-08-09

Review 8.  Immunological Dysfunction in Tourette Syndrome and Related Disorders.

Authors:  Chia-Jui Hsu; Lee-Chin Wong; Wang-Tso Lee
Journal:  Int J Mol Sci       Date:  2021-01-16       Impact factor: 5.923

9.  Association of Group A Streptococcus Exposure and Exacerbations of Chronic Tic Disorders: A Multinational Prospective Cohort Study.

Authors:  Davide Martino; Anette Schrag; Zacharias Anastasiou; Alan Apter; Noa Benaroya-Milstein; Maura Buttiglione; Francesco Cardona; Roberta Creti; Androulla Efstratiou; Tammy Hedderly; Isobel Heyman; Chaim Huyser; Marcos Madruga; Pablo Mir; Astrid Morer; Nanette Mol Debes; Natalie Moll; Norbert Müller; Kirsten Müller-Vahl; Alexander Munchau; Peter Nagy; Kerstin Jessica Plessen; Cesare Porcelli; Renata Rizzo; Veit Roessner; Jaana Schnell; Markus Schwarz; Liselotte Skov; Tamar Steinberg; Zsanett Tarnok; Susanne Walitza; Andrea Dietrich; Pieter J Hoekstra
Journal:  Neurology       Date:  2021-02-10       Impact factor: 9.910

10.  Allergic diseases influence symptom severity and T lymphocyte subgroups of children with tic disorders.

Authors:  Xiumei Liu; Xueming Wang; Xiaoling Zhang; Ai Hua Cao
Journal:  J Investig Med       Date:  2021-07-13       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.